Adam Taylor, MD
Adult Reconstructive Orthopaedic Surgery · Sacramento, CANPI 1427555804
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.3%), education and grants — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Stryker at 34.7% of the total. Reporting peaked in 2024 at $8,758 and has fallen 69.6% since, to $2,667 in 2025.
Across 145 payments — averaging $148.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$7K
- Smith+Nephew$7K
- Zimmer Biomet$3K
- Saxum Surgical, Inc.$1K
- Globus Medical$1K
- BD$397
- plus $822 from 8 others
What the payments were for
- Grants$3,33315%
- Travel & lodging$3,04014%
- Food & beverage$10,60949%
- Education$4,53321%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 79 | $7,460 |
| Smith+Nephew | 6 | $6,975 |
| Zimmer Biomet | 18 | $3,377 |
| Saxum Surgical, Inc. | 3 | $1,269 |
| Globus Medical | 26 | $1,216 |
| BD | 4 | $397 |
| Total Joint Orthopedics, Inc. | 1 | $177 |
| Johnson & Johnson(2 entities) | 2 | $171 |
| Davol Inc. | 1 | $163 |
| Orthalign Inc | 1 | $143 |
| Innovation Technologies Inc | 1 | $111 |
| Linvatec Corporation | 1 | $24 |
| KCI USA, Inc. | 1 | $18 |
| Convatec Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$3,548
- VARIAX$1,105
- Persona$1,059
- Avenir$986
- EVO Retrograde$475
- GAMMA$436
- T2$401
- PROFYLE$335
- OSS Orthopedic Salvage System$321
- ARISTA AH FLEXITIP$290
- REAL INTELLIGENCE$279
- AUGMENT INJECTABLE$270
- AXSOS$270
- HOFFMANN$270
- Arcos$258
- EXTERNAL FIXATION$168
- TRIATHLON$168
- ACCOLADE$168
- ORTHALIGN PLUS$143
- Journey II$137
How this compares
$21,516 in reported general payments places this provider in the 60th percentile of 136 adult reconstructive orthopaedic surgery providers in California.
See all adult reconstructive orthopaedic surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 32 | $142 |
| Ondansetron Hcl | 30 | $118 |
| Tramadol Hcl | 35 | $99 |
| Oxycodone Hcl | 29 | $96 |
| Omeprazole | 28 | $61 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Sacramento
- Gavin PereiraSacramento$78K
- Mauro GiordaniSacramento$50K
- William MaloneyStanford$11.1M
- James CaillouetteNewport Beach$4.8M
- William LongLos Angeles$2.8M
- John DearbornMenlo Park$2.5M
- William Bugbeela Jolla$2.1M
- James HuddlestonStanford$1.5M
- Alexander SahFremont$1.2M
- John DianaNapa$981K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.